Several novel compounds are attracting attention within the regenerative field. Retatrutide, a double GLP-1 and GIP receptor modulator, is showing promise for obesity regulation. BPC-157, or Body Protecting Peptide 157, is thought to promote wound regeneration, with varied studies on its results.